| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2170811 | Cytokine & Growth Factor Reviews | 2008 | 10 Pages | 
Abstract
												Crimean Congo hemorrhagic fever virus (CCHFV) causes an acute disease with the potential of a fatal outcome. The virus is prevalent in about 30 countries. Clinical symptoms of infection commonly include fever, myalgia, and hemorrhages. Levels of liver enzymes are raised, and bleeding markers are often increased. A role of inflammatory cytokines in the pathogenesis has been suggested, and CCHFV employs a range of passive and active mechanisms to avoid induction of the antiviral type I interferons. Here, we review the most recent findings on the molecular pathogenesis and the interaction of CCHFV with the type I interferon and cytokine responses and discuss implications for pathogenesis.
Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cell Biology
												
											Authors
												Friedemann Weber, Ali Mirazimi, 
											